At Optimapharm, we are committed to advancing research in rare diseases through innovative and efficient clinical trials. With 𝐨𝐯𝐞𝐫 𝟗𝟎 𝐜𝐥𝐢𝐧𝐢𝐜𝐚𝐥 𝐭𝐫𝐢𝐚𝐥𝐬 conducted across all phases and 𝟒𝟓 𝐝𝐢𝐟𝐟𝐞𝐫𝐞𝐧𝐭 𝐢𝐧𝐝𝐢𝐜𝐚𝐭𝐢𝐨𝐧𝐬, we are helping you expedite the development of new medicines, therapies and treatments that aim to improve the lives of millions living with rare diseases. Partnering with us means working with a highly educated, experienced, and proactive clinical research team. Our strong, trusted relationships with key opinion leaders globally ensure efficient and effective study execution, driving your research towards successful outcomes. Explore more our Rare Diseases expertise: https://lnkd.in/dwZVzzfg #RareDisease #RareDiseases #OrphanDrug #ClinicalResearch #ClinicalTrials
About us
Optimapharm is a globally operating, leading, mid-sized, full-service CRO aiming to deliver new therapies to improve and save patients’ lives. Optimapharm’s key priorities are our people and consistently exceeding our client’s expectations. With 26 strategically located offices across Europe, Optimapharm gives unrivalled access to Patients and Investigators worldwide. In-depth expertise and long-standing experience, combined with a flexible and collaborative approach, allow optimization of design and planning; through its strong track record of delivery excellence and committed and stable project teams, Optimapharm has secured a high level of repeat business over the years. Companies Figures • 510+ staff members • Excellence in delivery and superior project performance with an investigator network of 1000+ active sites • Close client relationship & high client retention rate of 85% • Highly educated workforce & low staff turnover rate; less than 15%, across the organization • Regional Cost-effective solutions ==== Full-service study delivery, Stand-alone service and Functional Service Provider are the 3 pillars Optimapharm offers to best respond to planned clinical development and efficiently resource clinical projects. • Regulatory Affairs • Medical Affairs • Medical Writing • Clinical Monitoring • Project Management • Data Management • Biostatistics • Safety and Vigilance • Quality • Translation Services OPTIMAPHARM's offices: - Austria - Belgium - Bosnia and Herzegovina - Bulgaria - Croatia - Czech Republic - Estonia - Finland - France - Georgia - Germany - Greece - Hungary - Lithuania - Republic of North Macedonia - Moldova - Poland - Romania - Serbia - Slovenia - Spain - Sweden - Switzerland - The United Kingdom - The United States of America
- Website
-
http://www.optimapharm.eu
External link for Optimapharm
- Industry
- Pharmaceutical Manufacturing
- Company size
- 501-1,000 employees
- Headquarters
- Zagreb
- Type
- Privately Held
- Founded
- 2005
- Specialties
- oncology, metabolic diseases, neurology, psychiatry, cardiovascular diseases, immunology, advanced therapies, rare diseases, pulmonary diseases, hemato-oncology, rheumatology, and steam cell therapies
Locations
Employees at Optimapharm
Updates
-
Clinical trials in dermatology are essential for continuous improvement of skin health and treatments. They ensure that new therapies are safe and effective, ultimately enhancing patient care. Having successfully completed over 30 dermatology clinical trials across phases I-IV, both in children and adults, we are dedicated to advancing dermatology treatment options and enhancing patients’ quality of life. Learn more about our dermatology expertise! Optimapharm - Your Dermatology CRO Expert! #ClinicalTrials #ClinicalResearch #Dermatology #DermatologyResearch #DermatologyTrials #CROCompany
-
In June, we celebrated a remarkable milestone – Optimapharm's 18th Anniversary! 🎉 For 18 operational years, our dedicated team has been the cornerstone of our success, growth, and excellence. We're immensely proud of all we’ve achieved together over the years. 🤝 Thank you to all our incredible employees for your hard work, dedication, and passion. We also extend our heartfelt gratitude to our clients and the patients who participate in our clinical trials and made our 18th anniversary possible. Here’s to many more years of success and collaboration! 🥂 To mark this special occasion, some of our offices celebrated these joyful moments with cake and refreshments. Check out how our special day went in some of our offices 🙌 #Anniversary #CompanyMilestone #TeamCelebration #Success #ThankYou #CelebrateTogether #Optimapharm
-
-
🌿 Embracing Sustainability and Health: Optimapharm No Meat Challenge Experience 🌿 We're excited to share that a group of our dedicated employees participated in the No Meat Challenge during the third week of June! This initiative aligns with the World Meat Free Day on June 15th, 2024, a special event encouraging at least 10 million people globally to go meat-free for one day. Our team came together to support this cause and promote awareness about the significant impact of meat production and consumption on our health and the environment. To enhance the experience, we created a Team Group where participants exchanged experiences, shared menu suggestions, and provided mutual support throughout the week. Each participant received a 7-day meatless menu along with a grocery list for meal preparation. We're proud of our employees' commitment to sustainability and healthier living. Here's to making small changes that lead to big impacts! 🌱🌏 #NoMeatChallenge #WorldMeatFreeDay #Sustainability #HealthyLiving #TeamSpirit #EnvironmentalAwareness
-
Excited to connect with inspirational women in the UK biotech sector this summer! 👩🔬✨ Join us at the #WomeninBiotech event in Bristol for thought-provoking panel discussions, invaluable networking opportunities, and insights from female leaders in life sciences. 🚀 If you're attending, don't miss the chance to connect with Poppy Gratton, Optimapharm's Business Development Director. Let's innovate and inspire together! 🤝💡 BioIndustry Association (BIA) #Biotech #WomenInScience #Networking #Innovation
-
June is Endometrial Cancer Awareness Month, a time dedicated to increasing awareness and promoting early detection of this common gynecologic cancer. 🌸Optimapharm is dedicated to finding better treatments for endometrial cancer, with a strong focus on innovation and research. Conducting 10 projects in the last five years, we relentlessly pursue advancements in medical science and patient outcomes. 🌸 Explore more our expertise in women's health in its global: https://lnkd.in/drQufw8f
-
Optimapharm team is excited to meet you at this year’s OCT UK and Ireland conference! 🤝 Visit us at booth #49 and meet our team of experts: Stiina Vuorio, Executive Director, Clinical Operations; Marie-Dominique G., Vice President, Sales and Marketing; and Poppy Gratton, Business Development Director. We are looking forward to sharing insights on how we can enhance your clinical operations and drive success. Connect with us to discover why Optimapharm is your first choice for a leading mid-sized, full-service CRO with a global reach. 🚀 #ClinicalTrials #ClinicalResearch #drugdevelopment #CRO #CROcompany #OCTUK #clinicaloperations
-
-
🌟 Hola from Madrid! 🌟 Optimapharm Team joined over 1,000 life sciences professionals in Madrid for the #VeevaSummit. Our Chief Operating Officer, Miguel Angel Salcedo, Senior Director, Trial Support, Jelena Pavlovic and Business Development Directors, Sara Babic Ljubojevic and Danilo Stancetic, are here to explore how industry leaders drive innovation through technology and collaboration. 🚀 We're excited to bring back new insights and ideas to drive our projects forward. #Innovation #TechInnovation
-
-
💡 Join us for the webinar "The Transformation of Pharmacovigilance through Innovative Technologies Enhancing Patient Safety.'' Julia Vera Martinez, Optimapharm's Director of Safety and Pharmacovigilance, will share her experiences as one of the panelists alongside experts from Oracle and Incyte. 🚀 In this PharmaLex-led session, discover how Large Language Models (like ChatGPT), "Classic" AI (e.g., machine learning) and Business Process Automation (BPA) are performing in actual #pharmacovigilance use cases. Explore what’s real vs. hype as experts in this panel will explore: ✅ Real-world examples of technology-driven safety processes ✅ Key considerations for evaluating tech solutions ✅ The evolving landscape of AI technologies and their impact on safety and clinical teams 🗓️ June 5th, 2024, at 10am ET / 16:00 CET Register now: https://lnkd.in/eSNUQs7s #PatientSafety #AIinHealthcare #cro
🚨 AI in Pharmacovigilance: Hype vs. Reality! 🚨 Curious about how Large Language Models (like ChatGPT), "Classic" AI (e.g., machine learning) and Business Process Automation (BPA) are performing in actual #pharmacovigilance use cases? Explore what’s real vs. hype in our upcoming webinar! 🗓️ Join us on June 5th, 2024, at 10am ET / 16:00 CET for "The Transformation of Pharmacovigilance through Innovative Technologies Enhancing Patient Safety." 💼 Featured Panelists: Michael Braun-Boghos from Oracle, Julia Vera Martinez from Optimapharm, Amardeep G.. from Incyte, and Iain Barnden from PharmaLex In this PharmaLex-led session, our panel of experts will explore: ✅ Real-world examples of technology-driven safety processes ✅ Key considerations for evaluating tech solutions ✅ The evolving landscape of AI technologies and their impact on safety and clinical teams Don't miss this opportunity to stay ahead in #pharmacovigilance and boost patient safety! Register now: https://lnkd.in/dUZ7fy_W #PharmaLex #PatientSafety #AIinHealthcare #Webinar
-
We are on the road again to meet you at OCT UK and Ireland 🤝 Stop by booth #49 and meet our team of experts Marie-Dominique G. – VP, Sales and Marketing, Poppy Gratton – Business Development Director, and Hassan Alli – Business Development Director, who will provide you with more information about the expertise and solutions we offer to meet your #clinicaltrials needs! Connect with us to discover why Optimapharm is your first choice for a leading mid-sized, full-service CRO with a global reach. 🗓️11-12 June, 2024 📍London, UK #clinicalresearch #clinicaloutsourcing #OCTUK #CRO Arena International Events Group Outsourcing in Clinical Trials Event Series